Call Us: 888-488-5750

Facebook Linkedin

VativoRx and Cooperton to Exhibit at the Puerto Rico Hospital Association Convention 2025

VativoRx and its sister company, Cooperton, are proud to announce their joint participation as exhibitors at the Puerto Rico Hospital Association Convention, taking place October 29–31, 2025, in San Juan, Puerto Rico.

Together, both companies bring a unique value proposition to Puerto Rico’s healthcare community—combining financial optimization through Strategic Rebate Management with next-generation cybersecurity and IT resilience designed specifically for healthcare institutions.

VativoRx will showcase its Medical & Pharmacy Rebate Program, a compliance-driven solution that helps hospitals and outpatient facilities recover unclaimed manufacturer rebates on high-cost specialty drugs under Medicare Parts A and B. Through advanced analytics, secure HITRUST-certified data exchange, and rigorous audit validation, VativoRx empowers providers to strengthen financial performance without disrupting care delivery.

Cooperton, a leader in cybersecurity, digital infrastructure, and enterprise IT solutions, will highlight how its healthcare technology services protect mission-critical data and ensure business continuity. The company’s participation underscores the growing importance of cybersecurity in the healthcare landscape—where data protection and operational integrity are now inseparable from financial sustainability.

As part of the convention agenda, William Bonaparte, Chief Operating Officer of Cooperton, will present the session:

“Tecnologías Emergentes y Ciberseguridad en el Sector Salud: Retos y Oportunidades para 2026”
(October 30, 3:00–3:30 PM)

Exploring how artificial intelligence and digital risk management are shaping cybersecurity governance and operational efficiency in healthcare institutions.

Healthcare executives, IT leaders, and financial decision-makers are invited to visit VativoRx and Cooperton at Booths #78–79 to explore how both companies are helping hospitals across Puerto Rico improve compliance, reduce risk, and uncover new revenue streams through secure, data-driven solutions.

To schedule a meeting during the event, contact us or cooperton.

Pharma Tariffs and Specialty Drug Cost Management: What Health Plans and TPAs Should Be Watching

On April 2nd, the White House signed a proclamation imposing new tariffs on patented pharmaceutical products under Section 232 of the Trade Expansion Act of 1962, the same national security trade authority underlying longstanding tariffs on steel and aluminum. The headline rate is 100%. But for health plans and TPAs managing specialty drug costs, that number requires context before it becomes useful for strategic rebate management and financial planning.

Read More »
April 17, 2026

When Drug Negotiation Reaches Part B

For years, Medicare drug price negotiation was mostly discussed as a Part D story. That changed in January, when CMS selected 15 drugs for the third cycle of negotiation, including the first drugs payable under Medicare Part B. Negotiations take place in 2026, and any negotiated prices from this cycle take effect in 2028.

Read More »
March 27, 2026